Yorke Justin W 4
4 · Processa Pharmaceuticals, Inc. · Filed Jan 4, 2023
Insider Transaction Report
Form 4
Yorke Justin W
Director
Transactions
- Award
Restricted Stock
2023-01-01+30,000→ 30,000 totalExercise: $0.00→ Common Stock (30,000 underlying) - Award
Common Stock
2022-12-31+18,208→ 33,093 total
Holdings
- 532,563(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]Vesting of time-based restricted shares.
- [F2]The restricted stock vests on the earliest of one year from date of grant or the next annual meeting of stockholders.